155 related articles for article (PubMed ID: 38494839)
21. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
Dong Y; Yuan Q; Ren J; Li H; Guo H; Guan H; Jiang X; Qi B; Li R
Front Endocrinol (Lausanne); 2023; 14():1090906. PubMed ID: 36860371
[TBL] [Abstract][Full Text] [Related]
23. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
Yan P; Cheng M; Wang L; Zhao W
Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
26. Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma.
Wu Y; Ren L; Tang Y; Zhu Z; Liu S; Jiang Y; Zhang S; Zhuang X; Chen Y
Aging (Albany NY); 2023 Oct; 15(20):11588-11610. PubMed ID: 37889539
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
29. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
30. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
[TBL] [Abstract][Full Text] [Related]
31. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
Zhao C; Zhou J; Xing J; Yin Q
Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
33. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
34. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
35. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
36. Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival.
Li H; Wu Z; Zhang Y; Lu X; Miao L
Front Oncol; 2023; 13():1201297. PubMed ID: 37377916
[TBL] [Abstract][Full Text] [Related]
37. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
Chen Z; Cheng G
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37691229
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-based critical gene biomarkers as prognostic reporters for gastric adenocarcinoma.
Zhang Z; Liao Y; Zhao P; Chen X; Liu Y; Wu J; Zuo H
Environ Toxicol; 2024 Mar; 39(3):1811-1821. PubMed ID: 38073300
[TBL] [Abstract][Full Text] [Related]
39. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]